
Could a Therapeutic HIV Vaccine Teach the Body to Fight Back?
A Phase I clinical trial has shown that a new DNA-based vaccine, ICVAX, is safe and successfully boosts immune responses in people living with HIV. By training T-cells to recognise the virus, this treatment aims to help the body control HIV without daily medication.


